Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
GRO Biosciences logo — GRObio’s groundbreaking science expands the amino acid alpha...

GRO Biosciences

GRObio’s groundbreaking science expands the amino acid alphabet to deliver on the promise of protein-based therapies.

Founded 2016 United States Boston, United States 32 employees Series B Total: $92.62M Biotechnology, Health Care +2

General Information

Company Name GRO Biosciences
Founded Year 2016
Location United States Boston, United States
Founders / Decision Makers
Team member Team member
Employees 32
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with GRO Biosciences. To contact GRO Biosciences, visit grobio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GRO Biosciences compare?

A PDF of GRO Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GRO Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GRO Biosciences

GRO Biosciences is a pioneering biotech startup founded in 2016 and headquartered in the United States. The company's slogan, "GRObio’s groundbreaking science expands the amino acid alphabet to deliver on the promise of protein-based therapies," encapsulates its mission to revolutionize protein therapeutics. GRO Biosciences is making waves in the Biotechnology and Pharmaceutical industries through its innovative approach, which involves transforming protein therapeutics with new amino acid building blocks to treat incurable diseases. The company recently secured a significant $25.00M Series A investment on 01 November 2021, demonstrating strong investor confidence in its vision and potential. Notable investors in this round include Innovation Endeavors, Redmile Group, Alumni Ventures Blockchain Fund, Digitalis Ventures, and Leaps by Bayer, adding further credibility to GRO Biosciences' growth trajectory. With this recent investment, GRO Biosciences is poised to advance its groundbreaking research and propel the development of novel protein-based therapies with expanded amino acid capabilities.

Business keywords: Protein Therapeutics, Synthetic Biology, Genomic Recoding, Computational Protein Design, Life Sciences, Bacterial Engineering, Medical Research, Drug Development, Biologics, Healthcare Innovation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $60.30M 6
Atlas Venture Innovation Endeavors Redmile Group
Atlas Venture, Innovation Endeavors +4
19 Jul 2024
Series A $25.00M 5
Innovation Endeavors Redmile Group Digitalis Ventures
Innovation Endeavors, Redmile Group +3
01 Nov 2021
Grant $1.20M 1
National Science Foundation
National Science Foundation
14 Sep 2020
Seed Round $3.50M 8
Pillar Innovation Endeavors Rising Tide
Pillar, Innovation Endeavors +6
13 Mar 2019
Grant $225.00K 1
National Science Foundation
National Science Foundation
29 Jan 2019
Seed Round $2.40M 7
Pillar Innovation Endeavors Rising Tide
Pillar, Innovation Endeavors +5
08 Feb 2018
Seed Round Undisclosed 1
Green D Ventures
Green D Ventures
16 Aug 2017

GRO Biosciences Alternatives & Competitors

View All Alternatives
GRO Biosciences vs
Enlaza Therapeutics
Enlaza Therapeutics United States

Pioneering Covalent Biologics

68 employees
Biopharma, Biotechnology
Compare GRO Biosciences vs Enlaza Therapeutics
GRO Biosciences vs
C4 Therapeutics, Inc.
C4 Therapeutics, Inc. United States

Clinical-stage biotech company transforming how disease is treated through targeted protein degradat...

IPO
111 employees
Biotechnology, Health Care
Compare GRO Biosciences vs C4 Therapeutics, Inc.
GRO Biosciences vs
SyntheX
SyntheX United States

Targeting the undruggable with synthetic biology-based drug discovery platforms

Venture round
26 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About GRO Biosciences

GRObio’s groundbreaking science expands the amino acid alphabet to deliver on the promise of protein-based therapies.
GRO Biosciences was founded in 2016.
GRO Biosciences is headquartered in Boston, United States.
GRO Biosciences operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on Protein Therapeutics, Synthetic Biology, Genomic Recoding and Computational Protein Design.
GRO Biosciences has approximately 32 employees.
GRO Biosciences has completed 7 funding rounds, raising a total of $92.62M. The latest funding stage is Series B.
Top alternatives and competitors to GRO Biosciences include Enlaza Therapeutics, C4 Therapeutics, Inc., SyntheX, Generate:Biomedicines, Asimov. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GRO Biosciences and Enlaza Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GRO Biosciences, https://bouncewatch.com/company/gro-biosciences, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout